Madrigal Pharmaceuticals

top of page

Apr 10

The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease

Bill Sibold describes how Madrigal has prepared for the launch and illustrates how the medicine is meant to impact disease progression.

Madrigal's CEO discusses the NASH field ahead of a key FDA decision date in March

Jan 9

Company News

Madrigal's CEO discusses the NASH field ahead of a key FDA decision date in March

Bill Sibold describes how resmetirom acts on fibrosis and could be the first commercial product in NASH.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Klein Hersh is a precision executive search firm with over 25 years of proven success partnering with clients to deliver the visionary leaders shaping the future of life sciences and healthcare. We believe that the innovation behind a healthier world starts with bringing the best and brightest minds together. Our experienced team of dedicated experts is deeply immersed in every facet of pharma, biotech, and healthcare, and has developed trusted relationships with far-reaching talent networks.

Visit Klein Hersh